Millennium Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.07M Sell
122,587
-553,323
-82% -$16.5M ﹤0.01% 3176
2025
Q4
$20.1M Buy
675,910
+385,023
+132% +$12.6M 0.01% 1571
2025
Q3
$10.5M Sell
290,887
-324,846
-53% -$10.7M ﹤0.01% 2339
2025
Q2
$22.2M Buy
615,733
+525,997
+586% +$19.6M 0.01% 1478
2025
Q1
$3.54M Buy
+89,736
New +$3.02M ﹤0.01% 3212
2024
Q4
Sell
-11,794
Closed -$276K 6457
2024
Q3
$276K Sell
11,794
-1,446,114
-99% -$31.6M ﹤0.01% 5254
2024
Q2
$25.9M Sell
1,457,908
-2,026,138
-58% -$32.3M 0.01% 1281
2024
Q1
$53M Buy
3,484,046
+555,258
+19% +$8.85M 0.02% 794
2023
Q4
$50M Buy
2,928,788
+912,357
+45% +$10.6M 0.02% 792
2023
Q3
$16.9M Buy
2,016,431
+1,181,301
+141% +$16.5M 0.01% 1572
2023
Q2
$20.7M Sell
835,130
-1,791,443
-68% -$46.3M 0.01% 1359
2023
Q1
$39.5M Sell
2,626,573
-3,566,599
-58% -$54.2M 0.02% 846
2022
Q4
$73.3M Buy
6,193,172
+2,230,975
+56% +$16.2M 0.04% 536
2022
Q3
$23.5M Sell
3,962,197
-996,355
-20% -$6.53M 0.01% 1203
2022
Q2
$21.1M Buy
4,958,552
+2,781,903
+128% +$17.4M 0.01% 1254
2022
Q1
$20.7M Buy
2,176,649
+1,640,258
+306% +$19M 0.01% 1360
2021
Q4
$10.2M Buy
536,391
+518,633
+2,921% +$13.5M 0.01% 2128
2021
Q3
$591K Sell
17,758
-101,456
-85% -$3.14M ﹤0.01% 5197
2021
Q2
$4.62M Sell
119,214
-197,257
-62% -$7.75M ﹤0.01% 2868
2021
Q1
$15.3M Sell
316,471
-228,105
-42% -$11M 0.01% 1340
2020
Q4
$28.3M Sell
544,576
-52,814
-9% -$1.78M 0.02% 809
2020
Q3
$16K Sell
597,390
-789,069
-57% -$18.2M 0.02% 932
2020
Q2
$27M Buy
1,386,459
+301,818
+28% +$4.86M 0.04% 571
2020
Q1
$10.7M Sell
1,084,641
-2,012,402
-65% -$25.4M 0.02% 815
2019
Q4
$34.4M Sell
3,097,043
-4,424,867
-59% -$33.6M 0.04% 537
2019
Q3
$42.2M Buy
7,521,910
+2,162,051
+40% +$15.1M 0.07% 376
2019
Q2
$46.4M Buy
5,359,859
+454,073
+9% +$3.43M 0.07% 370
2019
Q1
$39.4M Buy
4,905,786
+4,786,175
+4,001% +$25.9M 0.06% 432
2018
Q4
$490K Sell
119,611
-161,704
-57% -$804K ﹤0.01% 2985
2018
Q3
$1.57M Sell
281,315
-244,237
-46% -$2.79M ﹤0.01% 2603
2018
Q2
$6.91M Buy
525,552
+135,562
+35% +$1.86M 0.01% 1579
2018
Q1
$5.54M Buy
+389,990
New +$4.98M 0.01% 1737
2017
Q4
Sell
-132,401
Closed -$1.57M 4073
2017
Q3
$1.57M Buy
132,401
+95,027
+254% +$1.08M ﹤0.01% 2284
2017
Q2
$376K Sell
37,374
-153,253
-80% -$1.72M ﹤0.01% 2945
2017
Q1
$2.22M Buy
190,627
+44,901
+31% +$322K ﹤0.01% 1951
2016
Q4
$678K Buy
+145,726
New +$855K ﹤0.01% 2491
2016
Q3
Sell
-198,298
Closed -$1.2M 3601
2016
Q2
$1.2M Buy
+198,298
New +$1.61M ﹤0.01% 2051
2016
Q1
Sell
-158,125
Closed -$1.89M 3651
2015
Q4
$1.89M Buy
+158,125
New +$2M ﹤0.01% 1967
2015
Q3
Sell
-33,587
Closed -$557K 3729
2015
Q2
$557K Sell
33,587
-34,390
-51% -$545K ﹤0.01% 2589
2015
Q1
$1.05M Buy
+67,977
New +$1.03M ﹤0.01% 2287
2014
Q4
Sell
-136,877
Closed -$1.46M 4260
2014
Q3
$1.46M Sell
136,877
-133,845
-49% -$1.24M ﹤0.01% 2069
2014
Q2
$2.54M Buy
+270,722
New +$1.73M 0.01% 1619
2013
Q4
Sell
-169,749
Closed -$856K 3773
2013
Q3
$856K Buy
+169,749
New +$1.04M ﹤0.01% 2213

Other funds holding TGTX

Millennium Management's TGTX Position: Q1 2026 in Review

Millennium Management reduced its TG Therapeutics (TGTX) stake by 82% in Q1 2026, selling an estimated $16.5M and leaving 122,587 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3176.

Millennium Management first reported a position in TGTX in Q3 2013 and has held it in 43 quarters since. The position peaked at $73.3M in Q4 2022. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Millennium Management held 122,587 shares of TG Therapeutics worth $4.07M as of Q1 2026.
  • Millennium Management sold 553,323 TG Therapeutics shares in Q1 2026, an estimated $16.5M.
  • TG Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3176 holding.
  • Millennium Management first reported a position in TG Therapeutics in Q3 2013 and has held it in 43 quarters since.
  • Millennium Management's TG Therapeutics position peaked at $73.3M in Q4 2022.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.